phase readout
saveNCT07186946: Phase 1, Single Ascending Dose Study to Evaluate the Safety, Tolerability, PK, PD, and Comparative Bioavailability of THRV-1268 in Obese Adult Participants
COMPLETEDupdated 13h ago
community read0 votes
Sponsor: Thryv Therapeutics, Inc.. Phase: PHASE1. Conditions: Heart Failure
view source ↗
comments(0)
5-min edit window · permanent after that